The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti-inflammatory Therapeutics Market Research Report 2024

Global Anti-inflammatory Therapeutics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :

Report Code : 1431777

No of Pages : 83

Ask Your Query

Report Description
Table of Content

Synopsis

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

The global Anti-inflammatory Therapeutics market was valued at US$ 110540 million in 2023 and is anticipated to reach US$ 168130 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics.

Report Scope

The Anti-inflammatory Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-inflammatory Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA

Segment by Type

Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others

Segment by Application

Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

By Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Netherlands)
Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapeutics Market Perspective (2019-2030)
2.2 Anti-inflammatory Therapeutics Growth Trends by Region
2.2.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-inflammatory Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Anti-inflammatory Therapeutics Market Dynamics
2.3.1 Anti-inflammatory Therapeutics Industry Trends
2.3.2 Anti-inflammatory Therapeutics Market Drivers
2.3.3 Anti-inflammatory Therapeutics Market Challenges
2.3.4 Anti-inflammatory Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue
3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2023
3.5 Anti-inflammatory Therapeutics Key Players Head office and Area Served
3.6 Key Players Anti-inflammatory Therapeutics Product Solution and Service
3.7 Date of Enter into Anti-inflammatory Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapeutics Breakdown Data by Type
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2025-2030)
5 Anti-inflammatory Therapeutics Breakdown Data by Application
5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size (2019-2030)
6.2 North America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-inflammatory Therapeutics Market Size by Country (2019-2024)
6.4 North America Anti-inflammatory Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapeutics Market Size (2019-2030)
7.2 Europe Anti-inflammatory Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2019-2024)
7.4 Europe Anti-inflammatory Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-inflammatory Therapeutics Market Size (2019-2030)
9.2 Latin America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-inflammatory Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Anti-inflammatory Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Anti-inflammatory Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Detail
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Detail
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Detail
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapeutics Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapeutics Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Detail
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Detail
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapeutics Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2019-2024)
11.12.5 TEVA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}